Synthes: Market Segment Forecasts and Company Strategic Assessment
A strategic assessment of Synthes, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global orthopedics market.
Contains 30 pages
Contains 30 pages
SECTION 1: BUSINESS EVOLUTION AND ORGANIZATION
SECTION 2: FACILITIES AND EMPLOYEES
SECTION 3: TECHNOLOGICAL KNOW-HOW
SECTION 4: PRODUCT PORTFOLIO
SECTION 5: MARKETING TACTICS
SECTION 6: R&D EXPENDITURES AND MAJOR PROGRAMS
SECTION 7: STRATEGIC DIRECTION
SECTION 2: FACILITIES AND EMPLOYEES
SECTION 3: TECHNOLOGICAL KNOW-HOW
SECTION 4: PRODUCT PORTFOLIO
SECTION 5: MARKETING TACTICS
SECTION 6: R&D EXPENDITURES AND MAJOR PROGRAMS
SECTION 7: STRATEGIC DIRECTION
More Publications
2016-2020 Valproic Acid Test Volume and Sales Forecasts by Country and Market Segment-USA, EU5, Japan-Hospitals, Commercial Labs, POC Locations
US$ 600.00
March 2016
-
Critical Care Diagnostic Testing Market, 2019-2023: Ancillary Hospital Locations (ER, OR, ICU)--Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies
US$ 9,500.00
July 2019
973 pages
LDL Cholesterol Direct Test Volume and Sales Forecasts, 2019-2023: US, Europe, Japan-Hospitals, Commercial Labs, POC Locations
US$ 750.00
May 2019
-
2016-2020 Future Horizons and Growth Strategies in the Global Septicemia Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 3,480.00
March 2016
202 pages
Sirolimus Test Volume and Sales Forecasts 2021: US, Europe, Japan-Hospitals, Commercial Labs, POC Locations
US$ 750.00
September 2017
-
